Allena Pharmaceuticals
+$0.0009 (+0.10%) Today
-$0.0093 (-1.02%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNA and other ETFs, options, and stocks.
About ALNA
Allena Pharmaceuticals, Inc. engages in the development, discovery and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease.
CEO
Louis Brenner
Employees
41
Headquarters
Newton, Massachusetts
Founded
2011
ALNA Key Statistics
Market Cap
68.40M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
6.76M
High Today
$0.9399
Low Today
$0.8997
Open Price
$0.90
Volume
1.62M
52 Week High
$2.78
52 Week Low
$0.75
ALNA Earnings
-$0.51
-$0.34
-$0.17
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market